Authors: Atkins, WM Wang, RW Lu, AYH

Citation: Wm. Atkins et al., Allosteric behavior in cytochrome P450-dependent in vitro drug-drug interactions: A prospective based on conformational dynamics, CHEM RES T, 14(4), 2001, pp. 338-347

Authors: Lin, JH Lu, AYH

Citation: Jh. Lin et Ayh. Lu, Interindividual variability in inhibition and induction of cytochrome P450enzymes, ANN R PHARM, 41, 2001, pp. 535-567

Authors: Wang, RW Newton, DJ Liu, N Atkins, WM Lu, AYH

Citation: Rw. Wang et al., Human cytochrome P-450 3A4: In vitro drug-drug interaction patterns are substrate-dependent, DRUG META D, 28(3), 2000, pp. 360-366

Authors: Wang, RW Newton, DJ Liu, NY Shou, MG Rushmore, T Lu, AYH

Citation: Rw. Wang et al., Inhibitory anti-CYP3A4 peptide antibody: Mapping of inhibitory epitope andspecificity toward other CYP3A isoforms, DRUG META D, 27(2), 1999, pp. 167-172

Authors: Lu, AYH

Citation: Ayh. Lu, The 1996 Bernard B. Brodie Lecture - A journey in cytochrome P450 and drugmetabolism research, DRUG META D, 26(12), 1998, pp. 1168-1173

Authors: Lu, AYH

Citation: Ayh. Lu, Drug-metabolism research challenges in the new millennium - Individual variability in drug therapy and drug safety, DRUG META D, 26(12), 1998, pp. 1217-1222